1-20 of 21
Xiaonan Hou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1129: Interrogating JAK/STAT signaling in ovarian cancer as a potential oncogenic driver and therapeutic target

Esther Rodman, Michael Emch, Elizabeth Bruinsma, Xiaonan Hou, John Weroha, John Hawse
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1129.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1129
Published: 15 June 2022
View article
Journal Articles

Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer

Upasana Ray, Deok-Beom Jung, Ling Jin, Yinan Xiao, Subramanyam Dasari, Sayantani Sarkar Bhattacharya, Prabhu Thirusangu, Julie K. Staub, Debarshi Roy, Bhaskar Roy, S. John Weroha, Xiaonan Hou, James W. Purcell, Jamie N. Bakkum-Gamez, Scott H. Kaufmann, Nagarajan Kannan, Anirban K. Mitra, Viji Shridhar
Journal: Cancer Research
Cancer Res (2022) 82 (6): 1038–1054.
DOI: https://doi.org/10.1158/0008-5472.CAN-21-0622
Published: 15 March 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma

Arun Kanakkanthara, Xiaonan Hou, Thomas L. Ekstrom, Valentina Zanfagnin, Amelia M. Huehls, Rebecca L. Kelly, Husheng Ding, Melissa C. Larson, George Vasmatzis, Ann L. Oberg, Scott H. Kaufmann, Aaron S. Mansfield, S. John Weroha, Larry M. Karnitz
Journal: Cancer Research
Cancer Res (2022) 82 (2): 307–319.
DOI: https://doi.org/10.1158/0008-5472.CAN-21-0732
Published: 18 January 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments

Ki Hyun Yoo, Jason J. Tang, Mohammad Abdur Rashid, Chang Hoon Cho, Ana Corujo-Ramirez, Jonghoon Choi, Mun Gyeong Bae, Danielle Brogren, John R. Hawse, Xiaonan Hou, S. John Weroha, Alfredo Oliveros, Lindsey A. Kirkeby, Joseph A. Baur, Mi-Hyeon Jang
Journal: Cancer Research
Cancer Res (2021) 81 (13): 3727–3737.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-3290
Published: 01 July 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 1426: Multiomic analysis identifies CPT1A and fatty acid oxidation as a potential therapeutic target in platinum-refractory high grade serous ovarian cancer

Hong Wang, Dongqing Hugang, Shrabanti Chowdhury, Sara Savage, Richard Ivey, Jacob Kennedy, Jeffrey Whiteaker, Chenwei Lin, Xiaonan Hou, Catherine Huntoon, Uliana Voytovich, Zahra Shire, Qing Yu, Steven Gygi, Andrew Hoofnagle, Zachary Herbert, Anna Calinawan, Larry Karnitz, S. John Weroha, Scott Kaufmann, Bing Zhang, Pei Wang, Michael Birrer, Amanda Paulovich
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1426.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1426
Published: 01 July 2021
View article
Journal Articles

GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma

Zhiwei Dong, Kok Siong Yeo, Gonzalo Lopez, Cheng Zhang, Erin N. Dankert Eggum, Jo Lynne Rokita, Choong Yong Ung, Taylor M. Levee, Zuag Paj Her, Cassie J. Howe, Xiaonan Hou, Janine H. van Ree, Shuai Li, Shuning He, Ting Tao, Karen Fritchie, Jorge Torres-Mora, Julia S. Lehman, Alexander Meves, Gina L. Razidlo, Komal S. Rathi, S. John Weroha, A. Thomas Look, Jan M. van Deursen, Hu Li, Jennifer J. Westendorf, John M. Maris, Shizhen Zhu
Journal: Cancer Research
Cancer Res (2021) 81 (11): 2995–3007.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-1890
Published: 01 June 2021
View article
PDF
Includes: Supplementary data
Journal Articles

BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents

Arun Kanakkanthara, Kiran Kurmi, Thomas L. Ekstrom, Xiaonan Hou, Emma R. Purfeerst, Ethan P. Heinzen, Cristina Correia, Catherine J. Huntoon, Daniel O'Brien, Andrea E. Wahner Hendrickson, Sean C. Dowdy, Hu Li, Ann L. Oberg, Taro Hitosugi, Scott H. Kaufmann, S. John Weroha, Larry M. Karnitz
Journal: Cancer Research
Cancer Res (2019) 79 (23): 5920–5929.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-1405
Published: 02 December 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 4768: PARP inhibitor-induced autophagy provides an adaptive mechanism of drug resistance in preclinical models of ovarian cancer

Janice M. Santiago-O'Farrill, Saravut J. Weroha, Xiaonan Hou, Lan Pang, Philip Rask, Zhen Lu, Robert C. Bast
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4768.
DOI: https://doi.org/10.1158/1538-7445.AM2019-4768
Published: 01 July 2019
View article
Journal Articles

Abstract LB-127: Loss of function of GAS7 promotes neuroblastoma metastasis in the context of MYCN overexpression

Zhiwei Dong, Gonzalo Lepez Garcia, Cheng Zhang, Erin N. Dankert, Jo Lynne Harenza, Xiaonan Hou, Hu Li, John M. Maris, Shizhen (Jane) Zhu
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-127.
DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-127
Published: 01 July 2019
View article
Journal Articles

Abstract 5885: Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance

Rachel M. Hurley, Ksenija Nesic, Cordelia McGehee, Olga Kondrashova, Maria I. Harrell, Paula A. Schneider, Xiaonan Hou, Cristina Correia, Karen S. Flatten, Giada V. Zapparoli, Alexander Dobrovic, Kevin K. Lin, Thomas C. Harding, Andrea E. Wahner Hendrickson, Elizabeth M. Swisher, Matthew Wakefield, S. John Weroha, Clare L. Scott, Scott H. Kaufmann
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5885.
DOI: https://doi.org/10.1158/1538-7445.AM2018-5885
Published: 01 July 2018
View article
Journal Articles

Loss of FOXO1 Cooperates with TMPRSS2–ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion

Yinhui Yang, Alexandra M. Blee, Dejie Wang, Jian An, Yunqian Pan, Yuqian Yan, Tao Ma, Yundong He, Joseph Dugdale, Xiaonan Hou, Jun Zhang, S. John Weroha, Wei-Guo Zhu, Y. Alan Wang, Ronald A. DePinho, Wanhai Xu, Haojie Huang
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (23): 6524–6537.
DOI: https://doi.org/10.1158/0008-5472.CAN-17-0686
Published: 30 November 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 961: Inhibitors of fibrosis and TGF-beta delay tumor xenograft growth and reduce ascites in ovarian cancer models

Qing Zhang, Xiaonan Hou, Bradley J. Evans, John J. Weroha, William A. Cliby
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 961.
DOI: https://doi.org/10.1158/1538-7445.AM2017-961
Published: 01 July 2017
View article
Journal Articles

Abstract 4817: Regression of malignant ascites via PAPP-A inhibition in ovarian cancer patient-derived xenograft model

Valentina Zanfagnin, Laurie K. Bale, Marc A. Becker, Xiaonan Hou, Diogo Torres, Cheryl A. Conover, Saravut J. Weroha
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4817.
DOI: https://doi.org/10.1158/1538-7445.AM2017-4817
Published: 01 July 2017
View article
Journal Articles

Abstract 4814: Testing personalized therapies for ovarian cancer using mate pair genomic analysis and patient-derived xenografts

Konstantinos Leventakos, Faye R. Harris, Lin Yang, Xiaonan Hou, Saravut Weroha, Irina V. Kovtun
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4814.
DOI: https://doi.org/10.1158/1538-7445.AM2017-4814
Published: 01 July 2017
View article
Journal Articles

Abstract 1474: Characterization of 148 ovarian cancer tumografts (Avatars) using BROCA-HR deep sequencing

Kunal A. Lodhia, Marc A. Becker, Xiaonan Hou, Kimberly R. Kalli, Maria I. Harrell, Elizabeth M. Swisher, John S. Weroha, Paul Haluska
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1474.
DOI: https://doi.org/10.1158/1538-7445.AM2015-1474
Published: 01 August 2015
View article
Journal Articles

Abstract 1196: Overexpression of IGF-2 in primary patient ovarian cancer tumorgrafts increases bowel and thoracic metastasis

Xiaonan Hou, Marc A Becker, Saravut J Weroha, Kristina A Butler, Suzanne M Greiner, Paul Haluksa
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1196.
DOI: https://doi.org/10.1158/1538-7445.AM2014-1196
Published: 01 October 2014
View article
Journal Articles

Abstract 3274: Development of a clinically relevant in vivo model of ovarian cancer tumorgrafts in immunodeficient mice

Sergio Enderica Gonzalez, S. John Weroha, Marc Becker, Sean Harrington, Xiaonan Hou, Paul Haluska
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3274.
DOI: https://doi.org/10.1158/1538-7445.AM2012-3274
Published: 15 April 2012
View article
Journal Articles

Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer

Xiaonan Hou, Fei Huang, Luciana F. Macedo, Sean C. Harrington, Karen A. Reeves, Ann Greer, Friedrich Graf Finckenstein, Angela Brodie, Marco M. Gottardis, Joan M. Carboni, Paul Haluska
Journal: Cancer Research
Cancer Res (2011) 71 (24): 7597–7607.
DOI: https://doi.org/10.1158/0008-5472.CAN-11-1080
Published: 15 December 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 2283: Endoxifen exhibits potent in vitro and in vivo antitumor activity in ER+/HER2+ breast cancer and tamoxifen refractory tumors

Kathryn E. Reinicke, Xiaonan Hou, Matthew P. Goetz, Vera J. Suman, Mary J. Kuffel, Paul Haluska, Joel M. Reid, Matthew M. Ames
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2283.
DOI: https://doi.org/10.1158/1538-7445.AM2011-2283
Published: 15 April 2011
View article
Journal Articles

Abstract #1743: Combined estrogen signaling inhibition and IGF-1R/InsR inhibition with BMS-754807 in estrogen-dependent breast cancer model has synergistic antitumor activity in vitro and in vivo

Xiaonan hou, Joan M. Carboni, Luciana F Macedo, Sean C Harrington, Friedrich Finckenstein, Angela Brodie, Marco Gottardis, Paul Haluska
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1743.
Published: 01 May 2009
View article